Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Ondine Biomedical Inc. OBI.L
$17.79
-$0.69 (-3.86%)
На 18:05, 12 мая 2023
Ключевые показатели
-
Marketcap
36972668.00000000
-
week52high
45.65
-
week52low
14.97
-
Revenue
2569000
-
P/E TTM
-31
-
Beta
0.00000000
-
EPS
-0.16000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 07:54
Описание компании
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии